We are live on
!
Find out more
CFM
Catalyst Funds Management Portfolio holdings
AUM
$591M
1-Year Est. Return
71.09%
This Fund
S&P 500
This Quarter
Est. Return
+18.75%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$362M
AUM Growth
-$20.4M
(-5.3%)
Cap. Flow
-$61.6M
Cap. Flow
% of AUM
-17%
Top 10 Holdings %
Top 10 Hldgs %
19.16%
Holding
737
New
289
Increased
45
Reduced
94
Closed
308
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$9.8M |
| 2 |
Amphenol
APH
|
+$6.39M |
| 3 |
Applovin
APP
|
+$5.63M |
| 4 |
CRH
CRH
|
+$3.85M |
| 5 |
Insmed
INSM
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$11.7M |
| 2 |
Pfizer
PFE
|
+$7.17M |
| 3 |
NVIDIA
NVDA
|
+$7.15M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$7.02M |
| 5 |
Mastercard
MA
|
+$5.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Financials | 14.89% |
| 3 | Industrials | 12.22% |
| 4 | Materials | 11.64% |
| 5 | Healthcare | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Metagenomi Therapeutics
MGX
$45.6M
| $18.8K | 0.01% |
+12,700
| New | +$19.9K |
|
|
TPIC
427
DELISTED
TPI Composites
TPIC
| $18.6K | 0.01% |
+21,600
| New | +$22K |
|
428
Erasca
ERAS
$6.63B
| $16.6K | ﹤0.01% |
+13,061
| New | +$17.5K |
|
429
Ironwood Pharmaceuticals
IRWD
$611M
| $9.57K | ﹤0.01% |
13,340
-335,500
| -96% | -$263K |
|
430
AbbVie
ABBV
$458B
| – | – |
-6,300
| Closed | -$1.32M |
|
431
Archer Aviation
ACHR
$3.64B
| – | – |
-49,200
| Closed | -$350K |
|
432
Aclaris Therapeutics
ACRS
$730M
| – | – |
-16,698
| Closed | -$25.5K |
|
433
AES
AES
$10.6B
| – | – |
-207,600
| Closed | -$2.58M |
|
434
Atlas Energy Solutions
AESI
$1.49B
| – | – |
-10,800
| Closed | -$193K |
|
435
Agios Pharmaceuticals
AGIO
$2.16B
| – | – |
-11,200
| Closed | -$328K |
|
436
Alaska Air
ALK
$5.15B
| – | – |
-12,600
| Closed | -$620K |
|
437
Alkami Technology
ALKT
$1.8B
| – | – |
-10,800
| Closed | -$284K |
|
438
Allogene Therapeutics
ALLO
$601M
| – | – |
-14,580
| Closed | -$21.3K |
|
439
Alto Ingredients
ALTO
$360M
| – | – |
-17,557
| Closed | -$20K |
|
440
Antero Midstream
AM
$10.8B
| – | – |
-55,200
| Closed | -$994K |
|
441
Applied Materials
AMAT
$426B
| – | – |
-3,000
| Closed | -$435K |
|
|
OSG
442
Octave Specialty Group
OSG
$252M
| – | – |
-12,840
| Closed | -$112K |
|
443
Amgen
AMGN
$203B
| – | – |
-1,800
| Closed | -$561K |
|
444
Amylyx Pharmaceuticals
AMLX
$2.05B
| – | – |
-14,905
| Closed | -$52.8K |
|
445
Abercrombie & Fitch
ANF
$4.17B
| – | – |
-2,640
| Closed | -$202K |
|
446
Annexon
ANNX
$855M
| – | – |
-11,760
| Closed | -$22.7K |
|
447
APA Corp
APA
$12.8B
| – | – |
-121,500
| Closed | -$2.55M |
|
448
APi Group
APG
$17.1B
| – | – |
-58,350
| Closed | -$1.39M |
|
449
Ashland
ASH
$3.04B
| – | – |
-3,965
| Closed | -$235K |
|
450
AptarGroup
ATR
$8.45B
| – | – |
-5,700
| Closed | -$846K |
|
Similar funds
BBL
BA
DPRC
FL
MW
SM
LBIM
MPW
Catalyst Funds Management's Q2 2025 Portfolio in Review
As of Q2 2025, Catalyst Funds Management held 737 positions worth $362M, down 5.3% from $382M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Catalyst Funds Management withdrew a net $61.6M in Q2 2025, closing 308 positions and reducing 94 holdings. Its most notable exit was Pfizer, an estimated $7.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
Against the trend, Catalyst Funds Management opened a new position in VanEck Gold Miners ETF worth $10.3M.
- Catalyst Funds Management's largest Q2 2025 buy was VanEck Gold Miners ETF: 197,400 shares worth $10.3M.
- Catalyst Funds Management added most to Applovin in Q2 2025, an estimated $5.63M increase.
- Catalyst Funds Management's biggest Q2 2025 reduction was Rio Tinto, cutting an estimated $11.7M.
- Catalyst Funds Management fully exited Pfizer in Q2 2025, selling an estimated $7.17M.
- Catalyst Funds Management's ten largest holdings make up 19% of its $362M portfolio in Q2 2025.
- Catalyst Funds Management opened 289 new positions and closed 308 in Q2 2025.
- Catalyst Funds Management's portfolio value fell 5.3% quarter-over-quarter to $362M.
Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.